PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Piotroski F-Score: 6 (As of Jun. 30, 2026) — Near Median


ISX:DVLA PT Darya-Varia Laboratoria Tbk ISX:DVLA
73 GF Score
Price Rp1,595.00
GF Value Rp1,840.45
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is PT Darya-Varia Laboratoria Tbk Piotroski F-Score?

PT Darya-Varia Laboratoria Tbk ISX:DVLA 73 Piotroski F-Score is 6 as of Jun. 30, 2026, which is at its 10-year median of 6.00. GuruFocus rates ISX:DVLA with a GF Score™ of 73/100 and a GF Value™ of Rp1,840.45 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 978 Drug Manufacturers companies, PT Darya-Varia Laboratoria Tbk ranks better than 79.24% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

PT Darya-Varia Laboratoria Tbk has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for PT Darya-Varia Laboratoria Tbk's Piotroski F-Score or its related term are showing as below:

ISX:DVLA' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 6   Max: 9
Current: 6

During the past 13 years, the highest Piotroski F-Score of PT Darya-Varia Laboratoria Tbk was 9. The lowest was 2. And the median was 6.

PT Darya-Varia Laboratoria Tbk  (ISX:DVLA) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


PT Darya-Varia Laboratoria Tbk Piotroski F-Score Related Terms


PT Darya-Varia Laboratoria Tbk Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for PT Darya-Varia Laboratoria Tbk's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Darya-Varia Laboratoria Tbk Piotroski F-Score Chart

PT Darya-Varia Laboratoria Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.00 4.00 6.00 8.00 7.00

PT Darya-Varia Laboratoria Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.00 6.00 6.00 7.00 6.00

ISX:DVLA vs ZTS, UTHR, VTRS: Piotroski F-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, PT Darya-Varia Laboratoria Tbk's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Darya-Varia Laboratoria Tbk Piotroski F-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Darya-Varia Laboratoria Tbk's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where PT Darya-Varia Laboratoria Tbk's Piotroski F-Score falls into.


ISX:DVLA
73GF Score
PT Darya-Varia Laboratoria Tbk ISX:DVLA
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 42572.022 + 42891.35 + -383.279 + 55308.691 = Rp140,389 Mil.
Cash Flow from Operations was 94025.596 + 37225.287 + 9379.385 + 143989.129 = Rp284,619 Mil.
Revenue was 541806.854 + 542093.664 + 603555.249 + 594799.409 = Rp2,282,255 Mil.
Gross Profit was 284439.241 + 293128.669 + 326813.947 + 301377.724 = Rp1,205,760 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(2390355.519 + 2398047.676 + 2387924.398 + 2350265.761 + 2516208.197) / 5 = Rp2408560.3102 Mil.
Total Assets at the begining of this year (Mar25) was Rp2,390,356 Mil.
Long-Term Debt & Capital Lease Obligation was Rp0 Mil.
Total Current Assets was Rp1,831,262 Mil.
Total Current Liabilities was Rp780,931 Mil.
Net Income was 51868.476 + 28030.518 + 8759.202 + 78867.034 = Rp167,525 Mil.

Revenue was 554929.101 + 505446.01 + 494939.507 + 544293.044 = Rp2,099,608 Mil.
Gross Profit was 280712.324 + 272493.208 + 259169.427 + 308359.127 = Rp1,120,734 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(2200407.426 + 2228391.751 + 2251053.676 + 2161538.138 + 2390355.519) / 5 = Rp2246349.302 Mil.
Total Assets at the begining of last year (Mar24) was Rp2,200,407 Mil.
Long-Term Debt & Capital Lease Obligation was Rp481 Mil.
Total Current Assets was Rp1,741,067 Mil.
Total Current Liabilities was Rp706,357 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

PT Darya-Varia Laboratoria Tbk's current Net Income (TTM) was 140,389. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

PT Darya-Varia Laboratoria Tbk's current Cash Flow from Operations (TTM) was 284,619. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=140388.784/2390355.519
=0.05873134

ROA (Last Year)=Net Income/Total Assets (Mar24)
=167525.23/2200407.426
=0.07613373

PT Darya-Varia Laboratoria Tbk's return on assets of this year was 0.05873134. PT Darya-Varia Laboratoria Tbk's return on assets of last year was 0.07613373. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

PT Darya-Varia Laboratoria Tbk's current Net Income (TTM) was 140,389. PT Darya-Varia Laboratoria Tbk's current Cash Flow from Operations (TTM) was 284,619. ==> 284,619 > 140,389 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=0/2408560.3102
=0

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=480.859/2246349.302
=0.00021406

PT Darya-Varia Laboratoria Tbk's gearing of this year was 0. PT Darya-Varia Laboratoria Tbk's gearing of last year was 0.00021406. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=1831261.822/780931.446
=2.34497129

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=1741066.936/706356.981
=2.46485415

PT Darya-Varia Laboratoria Tbk's current ratio of this year was 2.34497129. PT Darya-Varia Laboratoria Tbk's current ratio of last year was 2.46485415. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

PT Darya-Varia Laboratoria Tbk's number of shares in issue this year was 1120. PT Darya-Varia Laboratoria Tbk's number of shares in issue last year was 1120. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=1205759.581/2282255.176
=0.52831935

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=1120734.086/2099607.662
=0.53378262

PT Darya-Varia Laboratoria Tbk's gross margin of this year was 0.52831935. PT Darya-Varia Laboratoria Tbk's gross margin of last year was 0.53378262. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=2282255.176/2390355.519
=0.95477646

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=2099607.662/2200407.426
=0.95419041

PT Darya-Varia Laboratoria Tbk's asset turnover of this year was 0.95477646. PT Darya-Varia Laboratoria Tbk's asset turnover of last year was 0.95419041. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+0+1+0+1
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

PT Darya-Varia Laboratoria Tbk has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 6 mean?
PT Darya-Varia Laboratoria Tbk (ISX:DVLA) has a Piotroski F-Score of 6 as of Jun. 30, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on PT Darya-Varia Laboratoria Tbk and its competitors. This is near median its historical median of 6.00. Over the past decade, PT Darya-Varia Laboratoria Tbk's Piotroski F-Score has ranged from 2.00 to 9.00. According to the industry distribution chart, PT Darya-Varia Laboratoria Tbk ranks #203 out of 978 companies in the Drug Manufacturers industry, placing it in the top 20.8%.
Is PT Darya-Varia Laboratoria Tbk's Piotroski F-Score too high?
PT Darya-Varia Laboratoria Tbk's current Piotroski F-Score of 6 is near median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 9.00. The Drug Manufacturers industry median Piotroski F-Score is 5.00. PT Darya-Varia Laboratoria Tbk's value of 6 is 20% above this industry median. Based on the distribution chart, PT Darya-Varia Laboratoria Tbk ranks #203 out of 978 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, PT Darya-Varia Laboratoria Tbk has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Darya-Varia Laboratoria Tbk's Piotroski F-Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PT Darya-Varia Laboratoria Tbk ranks #203 out of 978 companies for Piotroski F-Score. This places PT Darya-Varia Laboratoria Tbk in the top 21% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. PT Darya-Varia Laboratoria Tbk's value of 6 is 20% above this benchmark. Historically, PT Darya-Varia Laboratoria Tbk's own Piotroski F-Score has ranged from 2.00 to 9.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, PT Darya-Varia Laboratoria Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Drug Manufacturers company?
The median Piotroski F-Score among Drug Manufacturers companies is 5.00, based on 978 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Darya-Varia Laboratoria Tbk's current Piotroski F-Score of 6 is 20% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on PT Darya-Varia Laboratoria Tbk and its competitors. For the Drug Manufacturers industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Darya-Varia Laboratoria Tbk's current Piotroski F-Score is 6, which is near median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Darya-Varia Laboratoria Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Darya-Varia Laboratoria Tbk (ISX:DVLA) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp1,840.45, compared to a current price of Rp1,595.00 — trading 13.3% below its estimated fair value. The current Piotroski F-Score is 6, which is near median its 10-year median of 6.00 and 20% above the Drug Manufacturers industry median of 5.00. PT Darya-Varia Laboratoria Tbk's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For PT Darya-Varia Laboratoria Tbk (ISX:DVLA), the current Piotroski F-Score is 6 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Overvalued in 2026?

Based on GuruFocus' analysis, PT Darya-Varia Laboratoria Tbk stock appears to be undervalued. The current stock price of Rp1,595.00 is trading 13.3% below its estimated GF Value™ of Rp1,840.45. GuruFocus considers PT Darya-Varia Laboratoria Tbk to be Modestly Undervalued.

Key valuation signals for ISX:DVLA:

  • Piotroski F-Score: 6 (near median its 10-year median of 6.00)
  • GF Value™: Rp1,840.45 vs. price of Rp1,595.00 (13.3% below fair value)
  • GF Score™: 73/100 with 4 warning signs
  • Industry Position: 20% above the Drug Manufacturers median (#203 of 978)

No single metric tells the full story. See the ISX:DVLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Darya-Varia Laboratoria Tbk Business Description

Address Jalan. R.A. Kartini Kav. 8, 18th-19th Floor, South Quarter, Tower C, Jakarta, IDN, 12430
PT Darya-Varia Laboratoria Tbk (Darya-Varia) is operating in the pharmaceutical industry. It is engaged in the manufacture and trade of pharmaceutical products, human, traditional medicines, pharmaceutical materials, raw materials for traditional medicines, inorganic base chemicals, organic base chemicals, equipment for surgery, medical and dental care, and equipment, orthopedic equipment, prosthetic, eyeglasses, laboratory and health equipment from glass, cosmetics, wholesaler of pharmaceutical, traditional medicine, chemical base materials, laboratory testing services, periodic inspection services, and many more activities. Its business segments include: prescription drugs; consumer health products, which derives key revenue; export and toll manufacturing services; and services.
73GF Score

Get the complete analysis for ISX:DVLA

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp1,595.00
Price
Rp1,840.45
GF Value